ÂÜÀòÂÒÂ×

Daniel Byczkowski is a seasoned professional in clinical development with extensive experience in the pharmaceutical industry. Currently serving as Senior Manager of Clinical Development at Prolong Pharmaceuticals since January 2014, Daniel has previously held roles such as pRED Study Leader at Roche, Contract Senior Study Manager at Eisai Pharmaceuticals, and Assistant Director of Clinical Research at Abbott Laboratories, among others. Daniel's academic background includes a Master of Science in Biotechnology from William Paterson University and a Bachelor of Science in Exercise Science and Sport Studies from Rutgers University.